Molecular Monitoring of Imatinib in Chronic Myeloid Leukemia Patients in Complete Cytogenetic Remission: Does Achievement of a Stable Major Molecular Response at any Time Point Identify a Privileged Group of Patients? A Multicenter Experience in Argentina and Uruguay
Carolina Pavlovsky, Isabel Giere, Beatriz Moiraghi, Miguel A. Pavlovsky, Pedro Negri Aranguren, Juan García, Isolda Fernandez, Raquel Bengió, Jorge Milone, Valentin Labanca, Rosario Uriarte, VirginiaVolume:
11
Year:
2011
Language:
english
DOI:
10.1016/j.clml.2011.03.016
File:
PDF, 338 KB
english, 2011